Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Helius Medical Technologies, Inc. (NASDAQ: HSDT).

Full DD Report for HSDT

You must become a subscriber to view this report.


Recent News from (NASDAQ: HSDT)

Premarket analyst action - healthcare
Align Technology (NASDAQ: ALGN ) initiated with Outperform rating and $340 (18% upside) price target at Evercore ISI. More news on: Align Technology, Inc., Helius Medical Technologies, Inc., Baxter International Inc, Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 17 2018 08:41
Helius Medical Technologies announces uplisting to Nasdaq and pricing of Class A common stock and warrants
Helius Medical Technologies ( OTCQB:HSDT ) prices its public offering of ~2.1M shares of Class A common stock and warrants to purchase up to the same number of shares at a combined price of $7.47. More news on: Helius Medical Technologies, Inc., Healthcare stocks news, Read more ... ...
Source: SeekingAlpha
Date: April, 11 2018 08:33
Helius Medical Technologies, Inc. Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants
NEWTOWN, Pa., April 11, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (NASDAQ:HSDT) (“ Helius ” or the “ Company ”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants ...
Source: GlobeNewswire
Date: April, 11 2018 07:00
Helius Medical Technologies announces public offering of Class A common stock and warrants
Helius Medical Technologies ( OTCQB:HSDT ) intends to offer and sell, $16M shares of Class A common stock, together with warrants to purchase Class A common stock, in a public offering. More news on: Helius Medical Technologies, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 04 2018 08:27
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock and Warrants
NEWTOWN, Pa., April 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (OTCQB:HSDT) (“ Helius ” or the “ Company ”) announced today that it intends to offer and sell, subject to market conditions, $16 million of shares of its Class A common ...
Source: GlobeNewswire
Date: April, 04 2018 06:37
Helius Medical Technologies and HealthTech Connex Announce EEG Study Showing Stimulation by the Investigational PoNS® Device Impacts Brain Activity
NEWTOWN, Pa., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT)   (“Helius” or the “Company”), a medical technology company focused on neurological wellness, announced today that researchers hav...
Source: GlobeNewswire
Date: January, 08 2018 07:30
Helius Medical Technologies Selects Key Tronic Corporation as its Commercial Contract Manufacturing Partner
NEWTOWN, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”),  a medical technology company focused on neurological wellness, announced today that it has completed its co...
Source: GlobeNewswire
Date: January, 05 2018 08:00
Helius Medical Technologies Announces Planned Five-for-One Reverse Stock Split
NEWTOWN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”),  a medical technology company focused on neurological wellness, announced today that its board of directors ...
Source: GlobeNewswire
Date: January, 03 2018 18:49
Helius Medical Technologies Announces Closing of Final Tranche of Private Placement
NEWTOWN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”),  a medical technology company focused on neurological wellness, is pleased to announce the closing of the fi...
Source: GlobeNewswire
Date: December, 29 2017 18:45
Helius Medical Technologies Announces Closing of Second Tranche of Private Placement
NEWTOWN, Pa., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is pleased to announce the closing of the seco...
Source: GlobeNewswire
Date: December, 28 2017 19:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1811.3310.9211.3310.8616,869
2018-05-1711.3310.9211.3310.8616,869

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1412,42913,96089.0330Short
2018-08-137,3397,88993.0283Short
2018-08-1018,50025,90071.4286Short
2018-08-096,33714,33744.2003Short
2018-08-088,19311,10173.8042Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HSDT.


About Helius Medical Technologies, Inc. (NASDAQ: HSDT)

Logo for Helius Medical Technologies, Inc. (NASDAQ: HSDT)

Helius Medical Technologies Inc., is engaged primarily in the medical technology industry focused on neurological wellness. The Company s planned principal operations include the development, licensing and acquisition of unique and non invasive platform technologies to amplify the brain s ability to heal itself. The Company s first product in development, known as the portable neuromodulation stimulator or PoNS therapy platform, is designed to enhance the brain s ability to compensate for this damage. The PoNS therapy is a combination of a powerful, wearable, direct current stimulation device, and functional, targeted therapy, and is currently being developed for the treatment of movement, gait and balance disorders in patients with traumatic brain injury and other chronic neurological diseases

 

Contact Information

 

 

Current Management

  • Philippe Deschamps / President, CEO
  • Joyce LaViscount / CFO, COO
  • Kofi Berantuo / Contact Person
  • Dane Andreeff / Director
    • Mr. Andreeff, age , is the general partner and portfolio manager of Maple Leaf Partners, LP, a long/short value hedge fund, a position he has held since . Mr. Andreeff also serves as a member of the board of directors of TraceSecurity, LLC, HDL Therapeutics, Inc. and Myocardial Solutions, Ltd. Mr. Andreeff received his Bachelor s degree in Economics from the University of Texas at Arlington in and his Master s degree in Economics from the University of Texas at Arlington in . Our Board believes that Mr. Andreeff s extensive experience in the investment industry and capital markets will make him a valuable member of the Board.
  • Philippe Deschamps /
  • Thomas N. Griffin /
  • Huaizheng Peng /
  • Edward Straw /
  • Mitchell Tyler /
  • Blane Walter /

Current Share Structure

  • Market Cap: $224,559,200 - 03/16/2018
  • Issue and Outstanding: 20,241,135 - 03/05/2018

 


Recent Filings from (NASDAQ: HSDT)

Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 30 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 12 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: April, 11 2018
Filing Type: CERTFiling Source: edgar
Filing Date: April, 11 2018

 

 


Daily Technical Chart for (NASDAQ: HSDT)

Daily Technical Chart for (NASDAQ: HSDT)


Stay tuned for daily updates and more on (NASDAQ: HSDT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: HSDT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HSDT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of HSDT and does not buy, sell, or trade any shares of HSDT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/